🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Conversion Disorder

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma NCT07832006Phase 21 site📍 Beijing Shunda Du · Tests: Irreversible Electroporation, Lenvatinib, Sintilimab Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy NCT07789184Phase 331 sites📍 Beijing📍 Beijing📍 Beijing Hua Huang, MD, PhD · Tests: Radical Gastrectomy with D2 Lymphadenectomy, Standard Systemic Therapy for Advanced Gastric Cancer Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms NCT07033741n/a1 site📍 Turin University of Turin, Italy · Tests: EMDR Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer NCT07194005Phase 21 site📍 Shanghai Fudan University · Tests: Disitamab vedotin(RC48), Sintilimab, S-1, Oxaliplatin Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer NCT06405139Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Nanoliposomal Irinotecan, Oxaliplatin plus Capecitabine Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder NCT07527403n/a1 site📍 Rennes Hospital Center Guillaume Régnier · Tests: theta-burst rTMS (repetitive transcranial magnetic stimulation) Surgery for Locally Unresectable Pancreatic Cancer NCT07241663n/a1 site📍 Padova Azienda Ospedaliera di Padova · Tests: Questionnaire Study of Bladder-sphincter Symptoms in Functional Neurological Disorders NCT05689866n/a1 site📍 Bobigny Assistance Publique - Hôpitaux de Paris Evaluation of the Efficacy of Dissociation-Focused Cognitive Behavior Therapy NCT06917209NA8 sites📍 Angers📍 Lille📍 Montpellier University Hospital, Tours · Tests: CBT-CD psychotherapy Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer NCT06430658Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Tislelizumab (BGB-A317) with chemoradiotherapy Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604Phase 31 site📍 Gothenburg Sahlgrenska University Hospital · Tests: FOLFIRINOX or gemcitabine-nab-paclitaxel, FOLFIRINOX or gemcitabine-nab-paclitaxel Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer NCT07323056Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: Sacituzumab Tirumotecan and Limertinib AI-Driven Model Impact on Patient Engagement in Medically Assisted Reproduction NCT07087171n/a1 site📍 Lisbon Instituto Valenciano de Infertilidade de Lisboa · Tests: Artificial intelligence-Machine learning report with accurate personalized probabilities of having a live birth rate The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis. NCT06597526n/a1 site📍 Shanghai Ruijin Hospital EXPLOration of Processes Involved in Dissociative Identity Disorder (DID) NCT07663890n/a4 sites📍 Carvin📍 Chambray-lès-Tours📍 Lille Lille University · Tests: Questionnaire and Physical Exam, Interview Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC NCT06041477Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU, Concurrent Lenvatinib, Concurrent PD-1 antibody, Sequential L… Feasibility of Remotely Measured Activity Behavior for Individuals With Functional Neurologic Disorder NCT07478666n/a1 site📍 Denver University of Colorado, Denver FMT to Convert Response to Immunotherapy NCT05251389Phase 1, Phase 21 site📍 Amsterdam The Netherlands Cancer Institute · Tests: Fecal microbiota transplantation Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma NCT07560488Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Bevacizumab Biosimilar IBI305, ipilimumab N01, Sintilimab, HAIC Mechanistic Interventions and Neuroscience of Dissociation NCT04670640NA2 sites📍 Atlanta📍 Pittsburgh Emory University · Tests: Vibration, Breath Focus, No Distractions Neurofeedback and Well-Being Among People With Co-Occurring Obsessive Compulsive Disorder and Post-traumatic Stress Symptoms NCT07217925NA1 site📍 Detroit Wayne State University · Tests: Neuroptimal (Zengar, Inc.) Neurofeedback Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases NCT04687631Phase 31 site📍 Shanghai Fudan University · Tests: mFOLFOXIRI plus Cetuximab, mFOLFOXIRI Plus Bevacizumab Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma NCT06405321n/a1 site📍 Nanning Guangxi Medical University · Tests: Conversion or neoadjuvant therapy. Empowering Narratives NCT07062042NA1 site📍 Oslo Kristiania University College · Tests: Narrative Exposure Therapy First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury NCT06922890Phase 1, Phase 21 site📍 Seoul Yonsei University · Tests: STUP-001 The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intentions Among Patients With Functional Neurological Movement Disorders NCT07588282NA1 site📍 Graz Medical University of Graz · Tests: Psychoeducational communication guide for first-diagnosis of FND Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus NCT07483359Phase 21 site📍 Shenyang First Hospital of China Medical University · Tests: HAIC + Tislelizumab +lenvatinib Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma NCT07410715n/a1 site📍 Chengdu West China Hospital · Tests: Surgical Resection, Maintenance Therapy Group Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder. NCT06757296NA3 sites📍 Singapore📍 Singapore📍 Singapore Singapore Health Services · Tests: Endoscopic SASI
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy